Laurie Heilmann Named President of New CrownBio Global Life

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
714
Laurie Heilmann Named President of New CrownBio Global Life Science and Diagnostic Solutions Division

SAN DIEGO, June 06, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience , a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, today announces the appointment of Laurie Heilmann as President of CrownBio Global Life Science Product and Diagnostic Solutions. Heilmann will lead the newly formed division to achieve its mission of enabling scientists to access, discover and develop revolutionary drugs and diagnostics by providing cutting-edge solutions that transform scientific ideas into reality.   

“Laurie is a dynamic and visionary leader with an impressive record of success building and accelerating innovative biotechnology companies on a global scale,” said Jean-Pierre Wery, Ph.D., Crown Bioscience Chief Executive Officer. “As President of CrownBio Global Life Science and Diagnostic Solutions Division, Laurie will spearhead strategy development and commercialization of a unique portfolio of products and services that supports clinical and diagnostic markets across several therapeutic concentrations, including oncology, inflammation, cardiovascular, metabolic and neurological diseases.”

“This is an exciting opportunity to propel CrownBio Global Life Science and Diagnostic Solutions to a market leader position in life science and diagnostic spaces,” said Laurie Heilmann, former Chief Business Officer at Crown Bioscience. “It is a pivotal time in the industry as we move forward with game-changing products and services that support research from concept through commercialization and enable scientists to access, discover and develop innovative drugs and diagnostics across several therapeutic areas.”

Laurie possesses a diverse therapeutic background and has over three decades of global experience aligning sales and marketing with R&D to steer company strategy. As President of CrownBio Life Science Products and Diagnostics, Laurie will be responsible for charting new inroads of scientific and technological advancements to meet the needs of clinical and diagnostic markets across several therapy areas.

About Crown Bioscience Inc. Crown Bioscience is a global drug discovery and development solutions company providing translational platforms to advance oncology, inflammation, and metabolic disease research. With an extensive portfolio of relevant models and predictive tools, Crown Bioscience enables clients to deliver superior clinical candidates.

Media Enquiries: Jody Barbeau Crown Bioscience Inc. marketing@crownbio.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 41

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 37

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 45

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 30

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 34

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 25

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 58

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading

Top 5 Most Recently Viewed Articles

Bill Gates' Crossroads: Choosing Microsoft Over Harvard

Updated Category News Views 113

Bill Gates' Pivotal Decision Bill Gates, the co-founder of Microsoft, embarked on an intense journey during the early days of his company. Initially, he aimed to balance the demands of his blossoming software business with his studies at Harvard University. However, as the pressure mounted, he encountered a crucial decision that would shape his future. Struggling Between...

Continue Reading
Ensurge Micropower Invites Shareholders to Subscribe for New Shares

Updated Category News Views 63

Ensurge Micropower Announces Final Day for Share Subscription Ensurge Micropower ASA, known for its groundbreaking advancements in microbattery technology, has set the stage for a significant opportunity for shareholders. The subscription period for its subsequent offering, which consists of up to 22,222,222 new shares, is coming to a close. For those interested in...

Continue Reading
MongoDB Faces Class Action for Alleged Securities Violations

Updated Category News Views 57

Legal Challenges Facing MongoDB, Inc. MongoDB, Inc. (“MongoDB” or “the Company”) is currently embroiled in a class action lawsuit concerning alleged breaches of securities laws. This situation has sparked considerable concern among shareholders and investors about the company's transparency and the reliability of its financial practices. Overview of Allegations...

Continue Reading
Leading Edge Materials Updates Investors on Private Placement

Updated Category News Views 144

Leading Edge Materials Provides Update on Private Placement Leading Edge Materials Corp. (TSXV: LEM) has shared a significant update regarding its previously announced non-brokered private placement. This update is crucial for investors and stakeholders to understand the current status of the financing effort made by the company. The announcement clarifies that, as of the...

Continue Reading
Honoring Excellence in Community Development Financing Innovations

Updated Category News Views 214

Recognizing Leaders in Community Development Finance The Opportunity Honors bring attention to remarkable individuals and organizations shaping communities through dedicated efforts in community development finance. These awards shine a light on those who are committed to fostering economic growth and opportunity for all. Acknowledging the Contributions of Key Figures At...

Continue Reading